Cenobamate (ONTOZRY®), for the Treatment of Drug-Resistant Focal-Onset Seizures in Adults, Is Now Available in the Netherlands - Business Wire

Angelini Pharma, international pharmaceutical company part of the privately held Italian Angelini Group announced today that ONTOZRY® (cenobamate) is

PARIS--(BUSINESS WIRE)--Angelini Pharma, international pharmaceutical company part of the privately held Italian Angelini Group announced today that ONTOZRY® (cenobamate) is now available in the Neth… [+7596 chars]

full article...